Locey KJ, Lennon JT (2016) Scaling laws predict global microbial diversity. Proc Natl Acad Sci 113(21):5970–5975
Hawksworth DL, Lücking R (2017) Fungal diversity revisited: 2.2 to 3.8 million species. Microbiology Spectrum. 5(4):4–5
de Hoog GS, Ahmed SA, Danesi P, Guillot J, Gräser Y (2018) Distribution of pathogens and outbreak fungi in the fungal kingdom. In: Seyedmousavi S, de Hoog GS, Guillot J, Verweij P (eds) Emerging and epizootic fungal infections in animals. Springer, Dordrecht, pp 3–16
Hyde KD, Abdullah MSA, Andersen B, Boekhout T, Buzina W, Dawson TL Jr, Eastwood DC, Jones EBG, de Hoog S, Kang Y, Longcore JE, Richard-Forget F, Stadler M, Theelen B, Thongbai B, Tsui CKM (2018) The world’s ten most feared fungi. Fungal Diversity 93:161–194
Atiencia-Carrera MB, Cabezas-Mera FS, Tejera E, Machado A (2022) Prevalence of biofilms in Candida spp bloodstream infections: a metaanalysis. PLoS ONE 17(2):e0263522
Lopes JP, Lionakis MS (2022) Pathogenesis and virulence of Candida albicans. Virulence 13(1):89–121
Bates S (2008) Pathogenic fungi: insights in molecular biology. Expert Rev Anti Infect Ther 6(5):591–592
Kainz K, Bauer MA, Madeo F, Carmona-Gutierrez D (2020) Fungal infections in humans: the silent crisis. Microbial Cell 7(6):143–145
Xiao Z, Wang Q, Zhu F, An Y (2019) Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China. Antimicrob Resist Infect Control 8:89
Cavalheiro M, Teixeira MC (2018) Candida biofilms: threats, challenges, and promising strategies. Front Med (Lausanne) 5:28
Lo HJ, Kohler JR, DiDomenico B, Loebenberg L, Cacciapuoti A, Fink GR (1997) Nonfilamentous C albicans mutants are avirulent. Cell 90:939–949
Nunes CS, Kumar V (2018) Enzymes in human and animal nutrition: principles and perspectives. Academic Press 267–277
Calderone RA, Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9(7):327–335
Kurtzman CP, Meyerozyma Kurtzman & M, Suzuki (2010) In Kurtzman CP, Fell JW, Boekhout T, eds. The yeast. 5th ed. London, Elsevier; 2011; p 621–624.
Dujon B (2010) Yeast evolutionary genomics. Nat Rev Genet 11(7):512–524
Santos MA, Gomes AC, Santos MC, Carreto LC, Moura GR (2011) The genetic code of the fungal CTG clade. CR Biol 334(8):607–611
Sibirny AA, Boretsky YR (2009) Pichia guilliermondii. In: Satyanarayana T, Kunze G (eds) Yeast biotechnology: diversity and applications. Springer, Dordrecht, pp 113–134
Oslan SN, Salleh AB, Rahman RNZRA, Basri M, Chor ALT (2012) Locally isolated yeasts from Malaysia: identification phylogenetic study and characterization. Acta Biochim Pol 59(2):225–229
Oslan SN, Salleh AB, Rahman RNZRA, Leow TC, Sukamat H, Basri M (2015) A newly isolated yeast as an expression host for recombinant lipase. Cell Molecul Biol Lett 20(2):279–293
Valli M, Tatto NE, Peymann A, Gruber C, Landes N, Ekker H, Thallinger GG, Mattanovich D, Gasser B, Graf AB (2016) Curation of the genome annotation of Pichia pastoris (Komagataella phaffii) CBS7435 from gene level to protein function. FEMS Yeast Res 16(6):fow051
Mahyon NI (2017) Structural investigation of alcohol oxidase from Meyerozyma guilliermondii and the use of its promoter for recombinant protein expression. Master’s thesis. Universiti Putra Malaysia
Nasir NSM, Leow CT, Oslan SNH, Salleh AB, Oslan SN (2020) Molecular expression of a recombinant thermostable bacterial amylase from Geobacillus stearothermophilus SR74 using methanol-free Meyerozyma guilliermondii strain SO yeast system. BioResources 15(2):3161–3172
Castillo-Bejarano JI, Tamez-Rivera O, Mirabal-García M, Luengas-Bautista M, Montes-Figueroa AG, Fortes-Gutiérrez S, González-Saldaña N (2020) Invasive candidiasis due to Candida guilliermondii complex: epidemiology and antifungal susceptibility testing from a third-level pediatric center in Mexico. J Pediatric Infectious Diseases Soc 9(3):404–406
Deorukhkar SC, Saini S, Mathew S (2014) Non-albicans Candida infection: an emerging threat. Interdisciplinary perspectives on infectious diseases
Girmenia C, Pizzarelli G, Cristini F, Barchiesi F, Spreghini E, Scalise G, Martino P (2006) Candida guilliermondii fungemia in patients with hematologic malignancies. J Clin Microbiol 44(7):2458–2464
Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA (2010) Results from the ARTEMIS DISK global antifungal surveillance study 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole determined by CLSI standardized disk diffusion. J Clinic Microbiol 48(4):1366–1377
Tseng TY, Chen TC, Ho CM, Lin PC, Chou CH, Tsai CT, Wang JH, Chi CY, Ho MW (2017) Clinical features, antifungal susceptibility and outcome of Candida guilliermondii fungemia: an experience in a tertiary hospital in mid-Taiwan. J Microbiol Immunol Infect 51:552–558
Fitzpatrick DA, Logue ME, Stajich JE, Butler G (2006) A fungal phylogeny based on 42 complete genomes derived from supertree and combined gene analysis. BMC Evol Biol 6:99